PharmaSGP 

€28.8
4
+€0.2+0.7% Monday 06:08

Statistics

Day High
28.6
Day Low
28.6
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
17.14
Dividend Yield
0.17%
Dividend
0.05

Upcoming

Dividends

0.17%Dividend Yield
Jul 25
€0.05
Jul 24
€1.36
Jul 23
€0.49
Jun 22
€0.45
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
-51.93%
1Y Growth
-96.32%

Earnings

25SepExpected
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
0.27
0.35
0.42
0.5
Expected EPS
N/A
Actual EPS
N/A

Financials

16.44%Profit Margin
Profitable
2020
2021
2022
2023
2024
118.84MRevenue
19.54MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PSG.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for the treatment of hair loss; Dorisol for neuralgia (nerve pain), headaches, and migraines; Fulminan, a beauty drink; Lindaven, a pharmaceutical drops to treat their unpleasant problem; and SCLEROCALMAN, a drug for the treatment of clogged cerebral blood vessels. It also offers Prostacalman, a medication for cystitis and urination discomfort in a benign enlarged prostate; Revoten for women with weak connective tissue; Mindalin, a micronutrient drink for a healthy cardiovascular system; MELISTON, a prescription-free tablets to treat anxiety, restlessness, and mood swings; Deruba, a cream for skin redness; Lentisol that prevents the formation of new pigment spots; Neodolor, a headache tablet; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. The company sells its products through pharmacies and wholesalers. It also exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.
Show more...
CEO
Mr. Peter Gerckens
Employees
91
Country
DE
ISIN
DE000A2P4LJ5
WKN
000A2P4LJ

Listings

0 Comments

Share your thoughts

FAQ

What is PharmaSGP stock price today?
The current price of PSG.F is €28.8 EUR — it has increased by +0.7% in the past 24 hours. Watch PharmaSGP stock price performance more closely on the chart.
What is PharmaSGP stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange PharmaSGP stocks are traded under the ticker PSG.F.
Is PharmaSGP stock price growing?
PSG.F stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year PharmaSGP has showed a +20% increase.
What is PharmaSGP revenue for the last year?
PharmaSGP revenue for the last year amounts to 118.84M EUR.
What is PharmaSGP net income for the last year?
PSG.F net income for the last year is 19.54M EUR.
Does PharmaSGP pay dividends?
Yes, PSG.F dividends are paid annual. The last dividend per share was 0.05 EUR. As of today, Dividend Yield (FWD)% is 0.17%.
How many employees does PharmaSGP have?
As of April 01, 2026, the company has 91 employees.
In which sector is PharmaSGP located?
PharmaSGP operates in the Health Care sector.
When did PharmaSGP complete a stock split?
PharmaSGP has not had any recent stock splits.
Where is PharmaSGP headquartered?
PharmaSGP is headquartered in Gräfelfing, DE.